title: Neurocritical care in the treatment of stroke.
abstract: In this review, we briefly introduce recent developments and updates in neurocritical care in the treatment of stroke, including both ischemic and hemorrhagic stroke. Time to recanalization remains the major rate limiting step in the treatment of acute ischemic stroke as only a minority of patients arrive within a timeframe appropriate for treatment. Whether caring for a patient following ischemic or hemorrhagic stroke, the principle focus of neurocritical care for acute brain catastrophes is the identification and prevention of secondary brain injury. While much advancement is still needed for optimum care of patients suffering from ischemic or hemorrhagic stroke, the field continues to evolve in ways that promote improved patient outcomes.
authors.affiliation: a Department of Neurological Surgery , The Ohio State University Wexner Medical Center , Columbus , OH , USA.
authors.forename: David
authors.initials: D
authors.lastname: Dornbos Iii
authors.affiliation: a Department of Neurological Surgery , The Ohio State University Wexner Medical Center , Columbus , OH , USA.
authors.forename: Ciaran J
authors.initials: CJ
authors.lastname: Powers
authors.affiliation: b Department of Neurological Surgery , Wayne State University School of Medicine , Detroit , MI , USA.
authors.forename: Yuchuan
authors.initials: Y
authors.lastname: Ding
authors.affiliation: c Department of Neurology and Stroke Center , Beijing Tiantan Hospital, Capital Medical University , Beijing , China.
authors.forename: Liping
authors.initials: L
authors.lastname: Liu
mesh_terms: D019468:Disease Management; D057510:Endovascular Procedures / Q000379:methods*; D006801:Humans; D020521:Stroke / Q000628:therapy*; D017131:Thrombectomy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D010959:Tissue Plasminogen Activator
keywords: Endovascular thrombectomy; Hemorrhagic stroke; Ischemic stroke; Neurocritical care; Tissue plasminogen activator